Advancing Asia-Pacific Healthcare & Biopharma Innovation
In order to improve healthcare and hasten drug research in their home markets, some Asian-Pacific municipal governments have established sensible policies and laws within...
Generative AI in Pharma: Opportunities & Challenges
Regarding the readiness of the life sciences sector to successfully use generative AI in terms of infrastructure, regulatory considerations, and expertise, 67% of pharmaceutical...
Global Biopharma Market to Hit $566B by 2032
Global Biopharma Market Forecasts $566B By 2032 opposing Challenges
With a compound annual growth rate of almost 8%, from $263 billion in 2022 to $566...
Detect-ION and Moffitt Cancer Center Collaborate to Revolutionize Lung Cancer Early Detection
Detect-ION, the pioneering Deep-Tech startup headquartered in Tampa, Florida, has partnered with Moffitt Cancer Center for an ambitious venture to revolutionize lung cancer early...
Scaling Cell And Gene Therapies: Challenges And Solutions
It is not always easy to go from novel research to a working business plan. There are still problems with prices and safety, as...
The Cell & Gene Therapy – From Innovation To Market Growth
In 2023, the market for cell and gene therapy was worth USD 18.8 billion. In the years to come, the market is projected to...
Advances And Challenges In The Gene Therapy Manufacturing
Cell and gene treatments are now one of the pharmaceutical industry’s fastest-growing segments, with more and more being investigated for a variety of purposes.
The...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...